Analysts’ Updated EPS Estimates for January, 9th (ABT, ACGL, AVXS, COF, CXP, DCT, DFS, ELS, ESS, FAST)

Analysts’ updated eps estimates for Tuesday, January 9th:

Abbott Laboratories (NYSE:ABT) had its buy rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $65.00 price target on the stock.

Arch Capital Group (NASDAQ:ACGL) had its hold rating reiterated by analysts at Wells Fargo & Co. The firm currently has a $96.00 price target on the stock. The analysts wrote, “We are now including $67.5 million of cats, the mid-point of its previewed range. We had been including $57.5 million of cats in our model. As a result of the higher cats than we were modeling (due to the December fires) we are lowering our estimate to $1.20 (from $1.25) for the Q4 and $3.06 for FY 2017 (compared to our prior $3.12). Our 2018 and 2019 EPS estimates and price target are unchanged. Updated for cat losses outside of the October wildfires. The company now expects $60-75 million of pre-tax losses from Q4 cats (about 0.7-0.9% of its equity) from the California fires (October and December) and other global events, up from its prior estimate of $30-55 million of losses disclosed in its 10Q (the prior disclosure was only for the October wildfires). Most of the losses in the quarter stemmed from its non-U.S.””

AveXis (NASDAQ:AVXS) had its hold rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $92.00 target price on the stock.

Capital One Financial (NYSE:COF) had its buy rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $113.00 price target on the stock.

Columbia Property Trust (NYSE:CXP) had its buy rating reaffirmed by analysts at BMO Capital Markets. They currently have a $25.00 target price on the stock.

DCT Industrial Trust (NYSE:DCT) had its hold rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a $60.00 price target on the stock.

Discover Financial Services (NYSE:DFS) had its buy rating reissued by analysts at Royal Bank of Canada. They currently have a $107.00 target price on the stock.

Equity Lifestyle Properties (NYSE:ELS) had its hold rating reiterated by analysts at BMO Capital Markets. The firm currently has a $95.00 price target on the stock.

Essex Property Trust (NYSE:ESS) had its hold rating reiterated by analysts at BMO Capital Markets. BMO Capital Markets currently has a $250.00 target price on the stock.

Fastenal (NASDAQ:FAST) had its hold rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a $57.00 target price on the stock.

Federal Realty Investment Trust (NYSE:FRT) had its buy rating reiterated by analysts at BMO Capital Markets. The firm currently has a $142.00 target price on the stock.

Healthcare Trust Of America (NYSE:HTA) had its buy rating reissued by analysts at BMO Capital Markets. The firm currently has a $33.00 target price on the stock.

Johnson & Johnson (NYSE:JNJ) had its buy rating reaffirmed by analysts at Royal Bank of Canada.

Kilroy Realty (NYSE:KRC) had its buy rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a $79.00 target price on the stock.

Lipocine (NASDAQ:LPCN) had its buy rating reaffirmed by analysts at Canaccord Genuity. They currently have a $11.00 target price on the stock. The analysts wrote, “We eagerly anticipate Wednesday’s meeting and believe that Tlando could ultimately be approvable with adequate safety data in hand.””

Monmouth R.E. Inv. (NYSE:MNR) had its hold rating reiterated by analysts at BMO Capital Markets. BMO Capital Markets currently has a $18.00 target price on the stock.

Molina Healthcare (NYSE:MOH) had its target price boosted by Leerink Swann from $100.00 to $105.00. They currently have an outperform rating on the stock.

Norfolk Southern (NYSE:NSC) had its sell rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $137.00 target price on the stock.

SL Green Realty (NYSE:SLG) had its buy rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a $120.00 price target on the stock.

Stryker (NYSE:SYK) had its target price increased by Piper Jaffray Companies to $166.00. The firm currently has an overweight rating on the stock.

Stryker (NYSE:SYK) had its buy rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $175.00 price target on the stock.

Taubman Centers (NYSE:TCO) had its hold rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a $62.00 target price on the stock.

UDR (NYSE:UDR) had its hold rating reissued by analysts at BMO Capital Markets. They currently have a $40.00 target price on the stock.

U.S. Physical Therapy (NYSE:USPH) had its buy rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $80.00 price target on the stock. The analysts wrote, “After today’s market close, USPH released its preliminary estimates for the company’s 2018 consolidated tax rate; it estimates its effective rate will be within a range of 26-29%.””

Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply